CCAAT enhancer binding protein-β mRNA dynamics |
kd,C/EBP-βm (h−1) |
Degradation rate constant for C/EBP-β mRNA |
3.2 (35.0) |
|
Stimulation constant for C/EBP-β mRNA synthesis |
0.0038 (13.9) |
C/EBP-βm (0) |
Baseline C/EBP-β mRNA |
0.96 (3.9) |
Phosphoenolpyruvate carboxykinase mRNA and Protein Dynamics |
kGMD (h−1) |
First-order rate constant for GMD signal |
0.42 (20.3) |
kd,PEPCKm (h−1) |
Degradation rate constant for PEPCK mRNA |
0.053 (53.7) |
|
Stimulation constant for PEPCK mRNA synthesis |
0.17 (63.1) |
|
Stimulation constant for PEPCK mRNA degradation |
0.27 (59.8) |
kd,PEPCK (h−1) |
Degradation rate constant for PEPCK protein |
0.3 (41.9) |
γ
|
Power coefficient for PEPCK translation from mRNA |
0.0048 (fixed) |
kCREB (h−1) |
First-order rate constant for CREB signal |
2.77 (fixed) |
|
Stimulation constant for PEPCK protein - CREB |
0.004 (32.9) |
|
Stimulation constant for PEPCK protein - C/EBP-β |
0.001 (fixed) |
PEPCKm (0) (fmol/g) |
Baseline PEPCK mRNA |
209 |
PEPCK (0) |
Baseline PEPCK protein |
0.98 (8.6) |
Plasma glucose and insulin dynamics |
kd,Gluc (h−1) |
Degradation rate constant for glucose |
1.48 (fixed) |
|
Stimulation constant for glucose synthesis by PEPCK |
0.33 (17.8) |
|
Insulin sensitivity |
0.043 (77.2) |
Kd,Ins (h−1) |
Degradation rate constant for insulin |
0.049 (55.3) |
|
Glucose sensitivity |
0.5 (47.5) |
Glucose (0) (mg/dL) |
Baseline plasma glucose concentration |
148 |
Insulin (0) (ng/mL) |
Baseline plasma insulin concentration |
0.24 |